Difference between revisions of "SwitchAntipsychotics"
From Psychiatrienet
Line 39: | Line 39: | ||
| afk23 = Mz | med23 = Zuclopenthixol_MA | | | afk23 = Mz | med23 = Zuclopenthixol_MA | | ||
}} | }} | ||
− | '''ER''' = ''extended release (Xeplion® + Trivecta® + Byannli®)''', ''LA''' = ''long acting'', '''MA''' = ''medium acting | + | '''ER''' = ''extended release (Xeplion® + Trivecta® + Byannli®)''', ''LA''' = ''long acting'', '''MA''' = ''medium acting''<br /> |
[[category:Switchtable]] | [[category:Switchtable]] |
Revision as of 18:08, 18 March 2022
Switching Antipsychotics
To see the consequences of a switch between antipsychotics click in the crosstable below:
the switch is made "from" (vertical) "to" (horizontal).
During switching: don't reduce anticholinergics; consider adding oxazepam. Read: General considerations concerning switching antipsychotics.
Rest AP = Chlorprothixene, Flupentixol, Fluphenazine Loxapine, Pericyazine, Perphenazine,Promazine, Trifluoperazine, Ziprasidone, Zuclopentixol.
Partial agonist new = Aripiprazole, Brexpiprazole, Cariprazine.
ER = extended release (Xeplion® + Trivecta® + Byannli®), LA = long acting, MA = medium acting